I agree that this site is using cookies. You can find further informations here.
X
Prabhu, Kirti
138  results:
Search for persons X
?
1

Anticancer Potential and Molecular Targets of Pristimerin i..:

Prabhu, Kirti ; Jessy, Serah ; Kuttikrishnan, Shilpa...
Pharmaceuticals.  17 (2024)  5 - p. 578 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Non-Coding RNAs as Regulators and Markers for Targeting of ..:

Prabhu, Kirti ; Raza, Afsheen ; Karedath, Thasni...
Cancers.  12 (2020)  2 - p. 351 , 2020
Link: https://doi.org/10.3390/..
 
?
3

Impact of clinical pharmacy services in a short stay unit o..:

Abdelaziz, Hani ; Al Anany, Rasha ; Elmalik, Ashraf...
International Journal of Clinical Pharmacy.  38 (2016)  4 - p. 776-779 , 2016
Link: https://doi.org/10.1007/..
 
?
4

Formulation and Evaluation of Antiseptic Activity of the He..:

Lobo, Richard ; Prabhu, Kirti ; Shirwaikar, Annie..
Journal of Biologically Active Products from Nature.  1 (2011)  1 - p. 27-32 , 2011
Link: https://doi.org/10.1080/..
 
?
5

Bortezomib exerts its anti-cancer activity through the regu..:

Prabhu, Kirti S. ; Ahmad, Fareed ; Kuttikrishnan, Shilpa...
Cell Death Discovery.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
6

H2AX: A key player in DNA damage response and a promising t..:

Prabhu, Kirti S. ; Kuttikrishnan, Shilpa ; Ahmad, Nuha...
Biomedicine & Pharmacotherapy.  175 (2024)  - p. 116663 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Fatty acid synthase: A key driver of ovarian cancer metasta..:

Ahmad, Nuha ; Moton, Safwan ; Kuttikrishnan, Shilpa...
Pathology - Research and Practice.  260 (2024)  - p. 155465 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Network pharmacology, molecular simulation, and binding fre..:

Khan, Abbas ; Waheed, Yasir ; Kuttikrishnan, Shilpa...
Frontiers in Pharmacology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
9

Beyond genetics: Exploring the role of epigenetic alteratio..:

Prabhu, Kirti S. ; Sadida, Hana Q. ; Kuttikrishnan, Shilpa...
Pathology - Research and Practice.  254 (2024)  - p. 155174 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Exploring the in vivo anti-cancer potential of Neosetophomo..:

Kuttikrishnan, Shilpa ; Hasan, Maram ; Prabhu, Kirti S....
Experimental Cell Research.  435 (2024)  1 - p. 113907 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Integrative toxicogenomics: Advancing precision medicine an..:

Singh, Ajay Vikram ; Chandrasekar, Vaisali ; Paudel, Namuna...
Biomedicine & Pharmacotherapy.  163 (2023)  - p. 114784 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Serum immune mediators as novel predictors of response to a..:

Raza, Afsheen ; Mohsen, Reyad ; Kanbour, Aladdin...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
13

Neosetophomone B induces apoptosis in multiple myeloma cell..:

Kuttikrishnan, Shilpa ; Ahmad, Fareed ; Mateo, Jericha M....
Cell Biology International.  48 (2023)  2 - p. 190-200 , 2023
Link: https://doi.org/10.1002/..
 
?
14

In vitro evaluation of Neosetophomone B inducing apoptosis ..:

Kuttikrishnan, Shilpa ; Masoodi, Tariq ; Ahmad, Fareed...
Journal of Dermatological Science.  112 (2023)  2 - p. 83-91 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Corrigendum: Curcumin-mediated degradation of S-phase kinas..:

Khan, Abdul Q. ; Siveen, Kodappully S. ; Prabhu, Kirti S....
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
1-15